Clinical Trial Update: Long-term Safety and Performance of KiOmedine CM-Chitosan Supplementation in Advanced Symptomatic Knee Osteoarthritis [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing long-term safety and performance of KiOmedine CM-Chitosan supplementation in advanced symptomatic knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis Knee

Drugs mentioned

• KiOmedine CM-Chitosan (KiOmedine CM-Chitosan)

Snippet

Sponsor: Kiomed Pharma | Conditions: Osteoarthritis, Knee | Phase 4 | Status: UNKNOWN